Dr. David Holladay is now treating cancer patients with the following radiotherapy techniques:
IMRT (Intensity Modulated Radiation Therapy) - highly precise technique that targets tumors while sparing surrounding healthy tissue.
MammoSite® Radiation Therapy System (RTS) - a potential alternative to the traditional six-week radiation schedule prescribed for many breast cancer patients who have undergone lumpectomy.
Three-Dimensional Computerized Radiation Therapy (3D CRT) – uses CT scans to find all parts of the tumor and to select the best angles for the radiation beams to reduce radiation dose to surrounding healthy tissues.
Intracavity High-Dose Rate (HDR) and Low-Dose Rate (LDR) Brachytherapy – places radioactive sources near a tumor. With this technique, the tumor receives relatively high radiation doses while healthy tissue is spared. This can only be used on tumors that can be easily accessed or during surgery.
Interstitial Brachytherapy – implants radioactive material (small tubes, seeds or capsules) into the tumor. This can only be done for tumors that can be easily reached or during surgery.
Radiotherapy is performed at DeKalb Medical’s state-of-the-art Radiation Oncology Center. - The Radiation Oncology Center offers a Varian 21 EX linear accelerator with multileaf collimation, a Varisource 200 High Dose Brachytherapy unit, a GE CT simulator and Philips treatment planning system.
Cancer clinical trials are research studies to find better ways to treat cancer. Clinical trials often compare the most accepted cancer treatment with a new treatment that physicians hope will be more effective. What physicians learn during these trials will help you, as well as other people with cancer — now and in the future. For more detailed information on cancer research in Georgia, you can view DeKalb Medical’s Clinical Trials Brochure.
Dr. Holladay’s membership in several clinical trial research groups may offer treatment options for some patients. For more information about specific trials in which he is participating, call 404.501.7700.
Clinical Trial Research Groups in which Dr. Holladay is a member: